Home / Stocks / CRDF

CRDF insider trading

Cardiff Oncology, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
8
Bought · 24 mo
$2.8M
Buys · last 90 days
4 · $1.1M
Most recent buy
2026-07-16

Cluster buy detected

4 insiders bought CRDF within a short window (2026-06-18→2026-07-14), $1.1M in total — cluster score 76/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-16Mohindru Manicluster
Chief Executive Officer
Bought34,364$1.46$50k
2026-07-16PACE GARY Wcluster
Director
Bought687,285$1.46$1.0M
2026-06-22Mohindru Manicluster
Chief Executive Officer
Bought24,703$1.21$30k
2026-06-22PACE GARY Wcluster
Director
Bought30,000$1.22$37k
2025-07-31PACE GARY W
Director
Bought290,000$2.45$710k
2024-12-18Levine James E.cluster
Chief Financial Officer
Bought7,716$4.76$37k
2024-12-16TANNENBAUM RENEE Pcluster
Director
Bought10,000$3.42$34k
2024-12-12PACE GARY Wcluster
Director
Bought361,615$2.60$940k

Most active insider buyers

InsiderRoleBuysTotal bought
PACE GARY WDirector4$2.7M
Mohindru ManiChief Executive Officer2$80k
Levine James E.Chief Financial Officer1$37k
TANNENBAUM RENEE PDirector1$34k

See CRDF on the chart

Every insider buy and sell for CRDF plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.